US stocks opened on a mixed note this morning amid rising tensions on the border of Russia and Ukraine. The United States said Russia had amassed troops on the Ukrainian border to launch an invasion, Reuters reported.
Gainers
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab.